VTR
Ventas, Inc.Evidence as of 2026-09-02Overview · Ventas, Inc.
Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, r…
Management team
- Mr. Peter J. Bulgarelli · Executive Vice President of Outpatient Medical & ResearchFind on LinkedIn
- Ms. Carey Shea Roberts J.D. · Executive VP, General Counsel, Corporate Secretary and Ethics & Compliance OfficerFind on LinkedIn
- Mr. J. Justin Hutchens · Executive VP of Senior Housing & Chief Investment OfficerFind on LinkedIn
- Mr. Robert F. Probst · Executive VP & CFOFind on LinkedIn
Start your 7-day free trial to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
+0.2 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
What the evidence shows
The evidence balance is Mixed (+0.2 of a possible +2; was +0.2 before debate) · confidence high. Revenues in Q2 2026 (fiscal quarter ended 2026-07-28) rose to $ 1,729,614,000 from $ 1,420,893,000 in Q2 2025 (fiscal quarter ended 2025-07-28), while diluted EPS in Q2 2026 was $ 0.14 versus $ 0.15 in Q2 2025; diluted EPS in Q1 2026 (fiscal quarter ended 2026-04-24) was $ 0.11 versus $ 0.10 in Q1 2025. Common shares outstanding increased by about 110,484,780 shares (roughly +27%) from 402,461,579 as of 2024-02-07 to 512,946,359 as of 2026-07-28, and cash and cash equivalents fell from $ 897,850,000 as of 2024-12-31 to $ 198,956,000 as of 2026-06-30 while total assets rose to $ 29,655,896,000 and stockholders' equity to $ 14,649,399,000 (both as of 2026-06-30). Market measures show positive price momentum (3‑month +14.9%, 6‑month +7.1%, 12‑1 +37.9%), a constructive technical setup with a golden cross and price about 8.8% above the 200‑day SMA, elevated volatility (30‑day annualized 30.8%) and moderate drawdown history (3‑year max −16.4%, current −8.4%); valuation reads include a trailing‑12‑month P/E of 170.5, market cap $ 47,226,971,273, EV $ 60,039,031,273 and an operating‑cash‑flow yield on market cap of about 2.6%.
What the debate changed
The desk left the evidence balance unchanged at Mixed (+0.2). The bull and bear argued around tradeable signals and valuation sensitivity, but no surviving claim was dropped or materially weakened, so the read did not shift. The debate reinforced that operating cash flow is present and meaningful in the packet (OCF_ttm $ 1,225,016,000), even as key valuation multiples like EV/OCF (roughly 49x) highlight a stretched price relative to cash generation.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Total revenues for fiscal Q2 2026 (2026-04-01 to 2026-06-30, 3mo) were $1,729,614,000, up from $1,420,893,000 in fiscal Q2 2025 (2025-04-01 to 2025-06-30, 3mo).
XBRL companyfacts · 0000740260-26-000024Diluted earnings per share were $0.14 in fiscal Q2 2026 (2026-04-01 to 2026-06-30, 3mo) compared with $0.15 in fiscal Q2 2025 (2025-04-01 to 2025-06-30, 3mo), while diluted EPS was $0.11 in fiscal Q1 2026 (2026-01-01 to 2026-03-31, 3mo) versus $0.10 in fiscal Q1 2025 (2025-01-01 to 2025-03-31, 3mo).
XBRL companyfacts · 0000740260-26-000024Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
The Quarterly Report on Form 10-Q filed 30 July 2026 (fiscal quarter ended 30 June 2026) includes a prominent "Cautionary Statements" section and a forward-looking statements disclaimer that identifies numerous categories of risks (for example, exposure to evolving laws and regulations, macroeconomic conditions including inflation and interest rates, reliance on third-party managers and tenants, concentration among certain managers/tenants, credit and borrower default risk, construction and development risks, and debt and covenant-related risks).
10-Q filed 2026-07-30The Form 10-Q filed 30 July 2026 itemizes specific risk categories (labeled a through w) including cybersecurity and AI regulation, reimbursement and government funding risks for healthcare, concentration risk in managers and tenants, credit/default risk of borrowers, development and construction cost risks, and risks related to recognition of reserves, allowances, credit losses or impairment charges.
10-Q filed 2026-07-30Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
Price momentum is positive across horizons: 3‑month +14.9%, 6‑month +7.1%, and 12‑1 (12‑month minus 1‑month) +37.9%, with the 12‑1 momentum at the 77th percentile of the 547‑security research universe.
Moneyta signal set · 2026-09-01weakened in debateTrend signals are constructive by common technical measures: a golden cross is present, price is 8.8% above its 200‑day simple moving average and 0.5% below its 50‑day simple moving average as of 2026-09-01.
Moneyta signal set · 2026-09-01Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
13F-reported institutional holdings for the period ended 2026-03-31 total $38.87B with 928 holders, a quarter-over-quarter value change of 8.2% and a holder count delta of -2.
13F holdings · 928 filers · as of 2026-03-31BlackRock, Inc. is the largest 13F-reported holder at $4.63B as of the period ended 2026-03-31.
13F holdings · 928 filers · as of 2026-03-31Reads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
An article framed Ventas as potentially 'undervalued' in the context of senior housing growth (headline published 1 September 2026).
News · simplywall.st · 2026-09-01Rakuten Investment Management disclosed a new stake in Ventas valued at $7.05 million in a second-quarter 13F filing (article published 30 August 2026).
News · thelincolnianonline.com · 2026-08-30Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
On 2026-08-01 Andy Wattula (EVP OM&R-Ventas/Pres&CEO-LHS) reported two open-market acquisitions totaling $1,403,000 for 15,008 shares (10,694 shares for $1,000,000 at ~$93.53/share and 4,314 shares for $403,000 at ~$93.44/share).
Form 4 · Wattula Andy (EVP OM&R-Ventas/Pres&CEO-LHS) · $1000k code A · 2026-08-01On 2026-05-01 Peter J. Bulgarelli (EVP OM&R-Ventas/Pres&CEO-LHS) reported three acquisitions totaling $547,000 for 6,214 shares (2,346 shares for $206,000 at ~$87.84/share; 2,372 shares for $209,000 at ~$88.15/share; 1,496 shares for $132,000 at ~$88.23/share).
Form 4 · Bulgarelli Peter J. (EVP OM&R-Ventas/Pres&CEO-LHS) · $206k code F · 2026-05-01Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The reported trailing twelve-month price/earnings ratio is 170.5.
Valuation inputs · SEC XBRL + stored EOD closeTrailing twelve-month net cash provided by (used in) operating activities is $1,225,016,000.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
Several documented data points jointly support a favorable read: verified revenues materially increased year-over-year in Q2 2026 (fundamentals-0, strong filing evidence) while diluted EPS remained roughly stable across recent quarters (fundamentals-1, moderate strength), indicating operating scale alongside earnings resiliency. Balance-sheet expansion is recorded with total assets and stockholders' equity rising through mid‑2026 (fundamentals-4, strong filing evidence), and trailing twelve‑month operating cash flow is positive at $1.225B (valuation-1, direct calculation), which complements the institutional interest and reported new/added 13F positions and ETF inclusion (ownership-0/1/3 and news-1/2/3, moderate strength). Market technicals and momentum are constructive across multiple horizons and show a golden cross and price above the 200‑day MA (market-0/1, strong signal data), and multiple insider open‑market purchases in mid‑2026 provide corroborating behavioral evidence from company insiders (insider-0/1/2, moderate strength). These points together rebut a purely negative reading that focuses only on headline risks or valuation multiples by showing concurrent revenue growth, cash flow generation, institutional and insider accumulation, and positive price momentum (evidence strength ranges from moderate to strong across the cited items).
Chair's verdict, claim by claim
Fragility · computed, not argued
diversified0.28
35 surviving claims rest on 19 distinct sources; the heaviest analyst carries 17% of them, and 99% of what the desk raised survived the debate.
The evidence set is moderately broad (many surviving claims across nearly twenty sources) but not robustly independent: a single analyst accounts for a meaningful share of the surviving claims and most points survived internal debate. Given that almost all assertions persisted through review, the read is coherent but still somewhat fragile — treat individual claims as informative signals rather than definitive proof.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
28 filings· 1 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer−0.2 to the score
5 documents· 2 cited
SEC filing documents
The filings themselves, including the year-over-year comparison of Item 1A risk factors.
Read by Oakes−0.5 to the score
1 signal set
Moneyta signal set
Computed from our own end-of-day price history and ranked against the whole research universe. No AI involved.
Read by Nash+0.4 to the score
3 holdings records· 1 cited
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.4 to the score
8 headlines· 2 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
16 filings· 2 cited
Insider filings
Parsed Forms 3/4/5 from EDGAR: named insiders, share counts, prices, and 10b5-1 plan state — stated and inferred flags kept apart.
Read by Talbot+0.8 to the score
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only — it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on VTR Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.